- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.24 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.2: 2 residues within 4Å:- Chain A: H.136
- Chain C: D.10
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:H.136
SO4.25: 2 residues within 4Å:- Chain A: D.10
- Chain B: H.136
1 PLIP interactions:1 interactions with chain B- Salt bridges: B:H.136
SO4.48: 2 residues within 4Å:- Chain B: D.10
- Chain C: H.136
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:H.136
- 3 x GSH: GLUTATHIONE(Non-covalent)
GSH.3: 15 residues within 4Å:- Chain A: R.58, N.62, Y.66, Y.100, Y.104, R.111, L.115
- Chain C: S.30, V.33, I.34, R.37, P.44, P.45, Q.60
- Ligands: 01.23
10 PLIP interactions:6 interactions with chain A, 4 interactions with chain C- Hydrophobic interactions: A:Y.66
- Hydrogen bonds: A:N.62, A:Y.66, A:Y.66, A:R.111, C:S.30
- Salt bridges: A:R.58, C:R.37
- Water bridges: C:R.37, C:S.64
GSH.26: 15 residues within 4Å:- Chain A: S.30, V.33, I.34, R.37, P.44, P.45, Q.60
- Chain B: R.58, N.62, Y.66, Y.100, Y.104, R.111, L.115
- Ligands: 01.46
11 PLIP interactions:4 interactions with chain A, 7 interactions with chain B- Hydrogen bonds: A:S.30, B:N.62, B:Y.66, B:Y.66, B:Y.100, B:R.111
- Water bridges: A:R.37, A:S.64
- Salt bridges: A:R.37, B:R.58
- Hydrophobic interactions: B:Y.66
GSH.49: 15 residues within 4Å:- Chain B: S.30, V.33, I.34, R.37, P.44, P.45, Q.60
- Chain C: R.58, N.62, Y.66, Y.100, Y.104, R.111, L.115
- Ligands: 01.69
11 PLIP interactions:4 interactions with chain B, 7 interactions with chain C- Hydrogen bonds: B:S.30, C:N.62, C:Y.66, C:Y.66, C:Y.100, C:R.111
- Water bridges: B:R.37, B:S.64
- Salt bridges: B:R.37, C:R.58
- Hydrophobic interactions: C:Y.66
- 30 x PLM: PALMITIC ACID(Non-covalent)(Non-functional Binders)
PLM.4: 6 residues within 4Å:- Chain A: H.82, E.83, G.84, A.85, L.88
- Ligands: LMT.20
Ligand excluded by PLIPPLM.6: 3 residues within 4Å:- Chain A: F.95, L.98
- Ligands: PLM.7
Ligand excluded by PLIPPLM.7: 6 residues within 4Å:- Chain A: L.21, L.91, V.92, F.95
- Ligands: PLM.6, PLM.16
Ligand excluded by PLIPPLM.8: 4 residues within 4Å:- Chain A: L.138, L.142, A.145
- Ligands: PAM.13
Ligand excluded by PLIPPLM.9: 3 residues within 4Å:- Chain A: F.137
- Chain C: L.14
- Ligands: PAM.5
Ligand excluded by PLIPPLM.10: 6 residues within 4Å:- Chain A: A.72, I.79
- Chain C: L.71, W.75
- Ligands: PLM.33, PLM.56
Ligand excluded by PLIPPLM.16: 3 residues within 4Å:- Chain A: L.91
- Ligands: PLM.7, PAM.44
Ligand excluded by PLIPPLM.17: 6 residues within 4Å:- Chain A: R.99, Q.102, G.103, A.113, P.114, A.117
Ligand excluded by PLIPPLM.18: 1 residues within 4Å:- Ligands: PAM.15
Ligand excluded by PLIPPLM.22: 2 residues within 4Å:- Chain A: Y.28, Q.102
Ligand excluded by PLIPPLM.27: 6 residues within 4Å:- Chain B: H.82, E.83, G.84, A.85, L.88
- Ligands: LMT.43
Ligand excluded by PLIPPLM.29: 3 residues within 4Å:- Chain B: F.95, L.98
- Ligands: PLM.30
Ligand excluded by PLIPPLM.30: 6 residues within 4Å:- Chain B: L.21, L.91, V.92, F.95
- Ligands: PLM.29, PLM.39
Ligand excluded by PLIPPLM.31: 4 residues within 4Å:- Chain B: L.138, L.142, A.145
- Ligands: PAM.36
Ligand excluded by PLIPPLM.32: 3 residues within 4Å:- Chain A: L.14
- Chain B: F.137
- Ligands: PAM.28
Ligand excluded by PLIPPLM.33: 6 residues within 4Å:- Chain A: L.71, W.75
- Chain B: A.72, I.79
- Ligands: PLM.10, PLM.56
Ligand excluded by PLIPPLM.39: 3 residues within 4Å:- Chain B: L.91
- Ligands: PLM.30, PAM.67
Ligand excluded by PLIPPLM.40: 6 residues within 4Å:- Chain B: R.99, Q.102, G.103, A.113, P.114, A.117
Ligand excluded by PLIPPLM.41: 1 residues within 4Å:- Ligands: PAM.38
Ligand excluded by PLIPPLM.45: 2 residues within 4Å:- Chain B: Y.28, Q.102
Ligand excluded by PLIPPLM.50: 6 residues within 4Å:- Chain C: H.82, E.83, G.84, A.85, L.88
- Ligands: LMT.66
Ligand excluded by PLIPPLM.52: 3 residues within 4Å:- Chain C: F.95, L.98
- Ligands: PLM.53
Ligand excluded by PLIPPLM.53: 6 residues within 4Å:- Chain C: L.21, L.91, V.92, F.95
- Ligands: PLM.52, PLM.62
Ligand excluded by PLIPPLM.54: 4 residues within 4Å:- Chain C: L.138, L.142, A.145
- Ligands: PAM.59
Ligand excluded by PLIPPLM.55: 3 residues within 4Å:- Chain B: L.14
- Chain C: F.137
- Ligands: PAM.51
Ligand excluded by PLIPPLM.56: 6 residues within 4Å:- Chain B: L.71, W.75
- Chain C: A.72, I.79
- Ligands: PLM.10, PLM.33
Ligand excluded by PLIPPLM.62: 3 residues within 4Å:- Chain C: L.91
- Ligands: PAM.21, PLM.53
Ligand excluded by PLIPPLM.63: 6 residues within 4Å:- Chain C: R.99, Q.102, G.103, A.113, P.114, A.117
Ligand excluded by PLIPPLM.64: 1 residues within 4Å:- Ligands: PAM.61
Ligand excluded by PLIPPLM.68: 2 residues within 4Å:- Chain C: Y.28, Q.102
Ligand excluded by PLIP- 21 x PAM: PALMITOLEIC ACID(Non-covalent)(Non-functional Binders)
PAM.5: 9 residues within 4Å:- Chain A: A.130, L.133, L.134, F.137
- Chain C: D.10, A.13, L.14, E.83
- Ligands: PLM.9
Ligand excluded by PLIPPAM.11: 5 residues within 4Å:- Chain A: A.127, L.131, L.134
- Ligands: PAM.12, LMT.20
Ligand excluded by PLIPPAM.12: 7 residues within 4Å:- Chain A: W.123, V.126, A.127, A.130
- Chain C: L.24
- Ligands: PAM.11, LMT.19
Ligand excluded by PLIPPAM.13: 8 residues within 4Å:- Chain A: L.142, A.145, G.148, R.149, L.150, R.151
- Ligands: PLM.8, PAM.14
Ligand excluded by PLIPPAM.14: 1 residues within 4Å:- Ligands: PAM.13
Ligand excluded by PLIPPAM.15: 1 residues within 4Å:- Ligands: PLM.18
Ligand excluded by PLIPPAM.21: 4 residues within 4Å:- Chain C: L.14, A.17, L.91
- Ligands: PLM.62
Ligand excluded by PLIPPAM.28: 9 residues within 4Å:- Chain A: D.10, A.13, L.14, E.83
- Chain B: A.130, L.133, L.134, F.137
- Ligands: PLM.32
Ligand excluded by PLIPPAM.34: 5 residues within 4Å:- Chain B: A.127, L.131, L.134
- Ligands: PAM.35, LMT.43
Ligand excluded by PLIPPAM.35: 7 residues within 4Å:- Chain A: L.24
- Chain B: W.123, V.126, A.127, A.130
- Ligands: PAM.34, LMT.42
Ligand excluded by PLIPPAM.36: 8 residues within 4Å:- Chain B: L.142, A.145, G.148, R.149, L.150, R.151
- Ligands: PLM.31, PAM.37
Ligand excluded by PLIPPAM.37: 1 residues within 4Å:- Ligands: PAM.36
Ligand excluded by PLIPPAM.38: 1 residues within 4Å:- Ligands: PLM.41
Ligand excluded by PLIPPAM.44: 4 residues within 4Å:- Chain A: L.14, A.17, L.91
- Ligands: PLM.16
Ligand excluded by PLIPPAM.51: 9 residues within 4Å:- Chain B: D.10, A.13, L.14, E.83
- Chain C: A.130, L.133, L.134, F.137
- Ligands: PLM.55
Ligand excluded by PLIPPAM.57: 5 residues within 4Å:- Chain C: A.127, L.131, L.134
- Ligands: PAM.58, LMT.66
Ligand excluded by PLIPPAM.58: 7 residues within 4Å:- Chain B: L.24
- Chain C: W.123, V.126, A.127, A.130
- Ligands: PAM.57, LMT.65
Ligand excluded by PLIPPAM.59: 8 residues within 4Å:- Chain C: L.142, A.145, G.148, R.149, L.150, R.151
- Ligands: PLM.54, PAM.60
Ligand excluded by PLIPPAM.60: 1 residues within 4Å:- Ligands: PAM.59
Ligand excluded by PLIPPAM.61: 1 residues within 4Å:- Ligands: PLM.64
Ligand excluded by PLIPPAM.67: 4 residues within 4Å:- Chain B: L.14, A.17, L.91
- Ligands: PLM.39
Ligand excluded by PLIP- 6 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
LMT.19: 5 residues within 4Å:- Chain A: Y.116, R.120, W.123
- Ligands: PAM.12, 01.23
4 PLIP interactions:4 interactions with chain A- Hydrophobic interactions: A:W.123, A:W.123, A:W.123
- Hydrogen bonds: A:R.120
LMT.20: 6 residues within 4Å:- Chain A: F.81, H.82, A.85, L.131
- Ligands: PLM.4, PAM.11
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:H.82
LMT.42: 5 residues within 4Å:- Chain B: Y.116, R.120, W.123
- Ligands: PAM.35, 01.46
4 PLIP interactions:4 interactions with chain B- Hydrophobic interactions: B:W.123, B:W.123, B:W.123
- Hydrogen bonds: B:R.120
LMT.43: 6 residues within 4Å:- Chain B: F.81, H.82, A.85, L.131
- Ligands: PLM.27, PAM.34
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:H.82
LMT.65: 5 residues within 4Å:- Chain C: Y.116, R.120, W.123
- Ligands: PAM.58, 01.69
4 PLIP interactions:4 interactions with chain C- Hydrophobic interactions: C:W.123, C:W.123, C:W.123
- Hydrogen bonds: C:R.120
LMT.66: 6 residues within 4Å:- Chain C: F.81, H.82, A.85, L.131
- Ligands: PLM.50, PAM.57
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:H.82
- 3 x 01: 1-(phenylmethyl)-9-quinoxalin-2-yl-1,9-diazaspiro[5.5]undecan-2-one
01.23: 11 residues within 4Å:- Chain A: Y.66, L.69, A.119, L.122, W.123
- Chain C: V.23, A.27, S.30, L.31
- Ligands: GSH.3, LMT.19
10 PLIP interactions:3 interactions with chain C, 7 interactions with chain A- Hydrophobic interactions: C:V.23, C:A.27, C:L.31, A:Y.66, A:L.69, A:A.119, A:L.122, A:W.123
- pi-Stacking: A:W.123, A:W.123
01.46: 11 residues within 4Å:- Chain A: V.23, A.27, S.30, L.31
- Chain B: Y.66, L.69, A.119, L.122, W.123
- Ligands: GSH.26, LMT.42
10 PLIP interactions:7 interactions with chain B, 3 interactions with chain A- Hydrophobic interactions: B:Y.66, B:L.69, B:A.119, B:L.122, B:W.123, A:V.23, A:A.27, A:L.31
- pi-Stacking: B:W.123, B:W.123
01.69: 11 residues within 4Å:- Chain B: V.23, A.27, S.30, L.31
- Chain C: Y.66, L.69, A.119, L.122, W.123
- Ligands: GSH.49, LMT.65
10 PLIP interactions:7 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:Y.66, C:L.69, C:A.119, C:L.122, C:W.123, B:V.23, B:A.27, B:L.31
- pi-Stacking: C:W.123, C:W.123
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thoma, G. et al., Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase. J.Med.Chem. (2025)
- Release Date
- 2025-02-26
- Peptides
- Leukotriene C4 synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.24 Å
- Oligo State
- homo-trimer
- Ligands
- 3 x GOL: GLYCEROL(Non-functional Binders)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 3 x GSH: GLUTATHIONE(Non-covalent)
- 30 x PLM: PALMITIC ACID(Non-covalent)(Non-functional Binders)
- 21 x PAM: PALMITOLEIC ACID(Non-covalent)(Non-functional Binders)
- 6 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 3 x 01: 1-(phenylmethyl)-9-quinoxalin-2-yl-1,9-diazaspiro[5.5]undecan-2-one
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thoma, G. et al., Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase. J.Med.Chem. (2025)
- Release Date
- 2025-02-26
- Peptides
- Leukotriene C4 synthase: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
A - Membrane
-
We predict this structure to be a membrane protein.